Schobel Alexander Mark
CIK 0001406836
Chief Innovation/Tech Officer
Filings
9
Latest Oct 2, 2024
Issuers covered
1
Showing
9 of 9
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 67% | +11.9% | +16.6% | +35.3% | -16.1% |
| 90 days | 3 | 100% | +45.2% | +42.4% | +54.5% | +38.6% |
| 180 days | 3 | 100% | +10.9% | +13.1% | +18.7% | +0.9% |
| 365 days | 3 | 100% | +79.8% | +53.0% | +138.4% | +48.0% |
Issuers
Companies where Schobel Alexander Mark has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| AQST | Aquestive Therapeutics, Inc. | 9 | Oct 2, 2024 |
All filings
9 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|